PTPN11 Gen Mutasyonu: Noonan Sendrom’lu Bir Olgu
Noonan Sendromu, boy kısalığı, düşük arka saç çizgisi, yele boyun, göğüs duvarı deformiteleri, koagülasyon ve konjenital kalp defektleri ile karakterize ender bir genetik hastalıktır. Benzer klinik bulgular nedeniyle toplumda daha sık olarak karşılaşılan Turner sendromu ile karıştırılmaktadır. Bu çalışmada boy kısalığı nedeni ile kliniğimize başvuran 17 yaşında Noonan Sendromu tanısı alan bir olgu sunulmuştur
PTPN11 Gene Mutation: A Casewithnoonan Syndrome
Noonan syndrome is rare genetic disorder characterized with sort stature, low posterior hairline, webbed neck, chest wall deformities, coagulation and congenital heart defects. Because of similar clinical findings, Noonan syndrome is often misdiagnosed as Turner syndrome which is more common in population. In this study, a 17 years old patient who was admitted to our clinic with short stature and diagnosed Noonan syndrome is presented
___
- 1. Noonan JA, Ehmke DA. Associated noncardiac
malformations in children with congenital heart disease.
J Pediatr 1963; 31: 150-3.
- 2. Tartaglia M, Kalidas K, Shaw A, et al. PTPN11
mutations in Noonan syndrome: molecular spectrum,
genotype-phenotype correlation, and phenotypic
heterogeneity. Am J Hum Genet 2002; 70: 1555-63.
- 3. Croonen EA, Nillesen W, Schrander C, et al. Noonan
syndrome: Comparing mutation-positive with mutationnegative dutch patients. Mol Syndromol 2013; 4(5):
227-34.
- 4. Pandit B, Sarkozy A, Pennacchio LA, et. all. Gain-offunction RAF1 mutations cause Noonan and
LEOPARD syndromes with hypertrophic
cardiomyopathy. Nat Genet 2007; 39: 1007–12.
- 5. Schubbert S, Zenker M, Rowe SL, et. al. Germline
KRAS mutations cause Noonan syndrome. Nat
Genet 2006; 38: 331–6.
- 6. Nava C, Hanna N, Michot C, et al. CFC
and Noonan syndromes due to mutations in
RAS/MAPK signaling pathway: genotype/phenotype
relationships and overlap with Costello syndrome. J
Med Genet 2007; 44: 763–71.
- 7. Cirstea IC, Kutsche K, Dvorsky R, et al. A restricted
spectrum of NRAS mutations
causes Noonan syndrome. Nat Genet. 2010; 42: 27-9
- 8. Şimşek-Kiper PÖ, Alanay Y, Gülhan B, et al. Clinical
and molecular analysis of patients with RASopathies in
Turkish patients. Clin Genet 2012; 83(2): 181-6.
- 9. Binder G, Neuer K, Ranke MB, et al. PTPN11
mutations are associated with mild GH resistance in
individuals with Noonan syndrome. J Clin Endocrinol
Metab 2005; 90(9): 5377-81.
- 10. Digilio MC, Conti E, Sarkozy A, et al. Grouping of
multiple-Lentigines/LEOPARD and Noonan syndromes
on the PTPN11 gene. Am J Hum Genet 2002; 71(2):
389-94.
- 11. Van der Burgt I, Thoonen G, Roosenboom N, et al.
Patterns of cognitive functioning in school-aged
children with Noonan syndrome associated with
variability in phenotypic expression. J Pediatr 1999;
135(6): 707-13.